RHEUMATOID ARTHRITIS DIAGNOSTIC TESTS MARKET ANALYSIS

Rheumatoid Arthritis Diagnostic Tests Market,Rheumatoid Arthritis Diagnostic Tests Market, By Test Type (Serology Test (Erythrocyte Sedimentation Rate (ESR), Rheumatoid Factor (RF), Anti-cyclic Citrullinated Peptide (anti-CCP), Antinuclear Antibody (ANA), Uric Acid, Other Tests), Monitoring RA Treatment Efficiency Tests (Salicylate Level Count, Muscle Enzyme Tests (CPK, Aldolase), Creatinine Test)), By End User (Diagnostic Laboratories, Private Laboratories, Public Laboratories, Ambulatory Surgical Centers), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Jun 2023
Code : CMI3716
Pages :165
Formats :
Excel and PDF
Industry : Clinical Diagnostic

Market Challenges And Opportunities

Limited specificity and sensitivity of test kits

Global Rheumatoid Arthritis Diagnostic Tests Market: Restraint

Limited specificity and sensitivity of test kits

Limited specificity and sensitivity of test kits available in the market is expected to hinder growth of the global rheumatoid arthritis diagnostic tests market. For instance, according to article published in biomedical phamcology journal in may 2021, reported determination of specificity and sensitivity of rheumatoid factor and anti ccp tests in patients with ra in private clinic in Tehran. 110 individuals out of RA group (25.7%) were Anti-CCP negative and the others (74.3%) were positive. While 375 individuals out of non-RA group (92.8%) were Anti-CCP negative and the others (7.2%) were positive.